PAYSNasdaqServices-Business Services, NECFiscal year ends December 31
Paysign, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$15.34+0.54 (+3.65%)
Close on Oct 19, 2026
- Market cap
- $950.70M
- P/E (TTM)
- 59.0
- Dividend yield
- –
Paysign, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Plasma Industry [Member] | $50.25M | $47.95M | $45.62M | $43.81M | $42.39M | $42.92M | $43.88M | $44.60M | $44.22M | $42.96M | $41.95M | $40.14M | 49.9% | +18.5% |
| Pharma Industry [Member] | $47.84M | $40.95M | $33.89M | $28.61M | $23.96M | $18.88M | $12.65M | – | – | – | – | – | 47.5% | +99.7% |
| Other Revenue [Member] | $2.55M | $2.56M | $2.52M | $2.46M | $2.19M | $1.99M | $1.85M | $1.83M | $1.60M | $1.51M | $1.27M | $980.01K | 2.5% | +16.5% |
| Pharmaceutical Industry [Member] | – | – | – | – | – | – | – | $10.04M | $7.80M | $5.85M | $4.05M | $3.08M | – | – |
By region
From the segment and revenue-disaggregation notes of Paysign's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.